A lower level of CD25, CD71, CD69, and HLA-DR antigen expression was found in patients at all observation times and in pre-T1D subjects after administration of 1 μg/ml of PHA showed a significantly reduced expression of CD69 and CD71 [65]. The gene discussed is TFRC; the disease is type 1 diabetes mellitus.